Comparative effectiveness of sotorasib versus docetaxel in second line and beyond (2L+) among patients with advanced non-small cell lung cancer (NSCLC) in the Flatiron Health (FH) Enhanced Datamart (EDM)First published 25/03/2024 Last updated 15/10/2024 EU PAS number: EUPAS1000000056StudyOngoing